CAM
NVO

Claret Asset Management’s Novo Nordisk NVO Stock Holding History

Claret Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.78M Buy
157,347
+4,737
+3% +$224K 0.69% 36
2025
Q4 		$7.76M Buy
152,610
+7,612
+5% +$389K 0.9% 29
2025
Q3 		$8.05M Buy
144,998
+114,568
+376% +$6.71M 0.96% 27
2025
Q2 		$2.1M Buy
30,430
+101
+0.3% +$6.87K 0.27% 55
2025
Q1 		$2.11M Buy
30,329
+117
+0.4% +$9.66K 0.3% 49
2024
Q4 		$2.6M Buy
30,212
+22,921
+314% +$2.48M 0.41% 47
2024
Q3 		$868K Hold
7,291
– – 0.14% 74
2024
Q2 		$1.04M Sell
7,291
-675
-8% -$89.4K 0.19% 64
2024
Q1 		$1.02M Buy
7,966
+650
+9% +$77.4K 0.17% 67
2023
Q4 		$757K Hold
7,316
– – 0.14% 79
2023
Q3 		$665K Buy
7,316
+66
+0.9% +$5.81K 0.13% 77
2023
Q2 		$587K Hold
7,250
– – 0.11% 85
2023
Q1 		$577K Hold
7,250
– – 0.11% 89
2022
Q4 		$491K Hold
7,250
– – 0.11% 92
2022
Q3 		$361K Hold
7,250
– – 0.09% 98
2022
Q2 		$404K Hold
7,250
– – 0.09% 101
2022
Q1 		$403K Hold
7,250
– – 0.08% 103
2021
Q4 		$406K Sell
7,250
-72
-1% -$3.9K 0.08% 112
2021
Q3 		$351K Hold
7,322
– – 0.06% 124
2021
Q2 		$307K Hold
7,322
– – 0.05% 141
2021
Q1 		$247K Hold
7,322
– – 0.05% 151
2020
Q4 		$256K Sell
7,322
-616
-8% -$21.3K 0.05% 148
2020
Q3 		$276K Hold
7,938
– – 0.06% 136
2020
Q2 		$260K Sell
7,938
-7,980
-50% -$255K 0.06% 138
2020
Q1 		$479K Sell
15,918
-3,410
-18% -$102K 0.14% 88
2019
Q4 		$559K Sell
19,328
-138
-0.7% -$3.82K 0.11% 103
2019
Q3 		$503K Sell
19,466
-94
-0.5% -$2.38K 0.1% 104
2019
Q2 		$499K Hold
19,560
– – 0.1% 107
2019
Q1 		$512K Buy
19,560
+94
+0.5% +$2.31K 0.1% 106
2018
Q4 		$448K Hold
19,466
– – 0.1% 109
2018
Q3 		$459K Buy
19,466
+1,808
+10% +$44.1K 0.09% 114
2018
Q2 		$407K Buy
17,658
+9,000
+104% +$214K 0.08% 118
2018
Q1 		$213K Hold
8,658
– – 0.05% 144
2017
Q4 		$232K Buy
+8,658
New +$220K 0.05% 140

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Claret Asset Management's NVO Position: Q1 2026 in Review

Claret Asset Management increased its Novo Nordisk (NVO) stake by 3.1% in Q1 2026, buying an estimated $224K and bringing the position to 157,347 shares worth $5.78M. The position accounts for 0.69% of the portfolio, ranked #36.

Claret Asset Management first reported a position in NVO in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.05M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Claret Asset Management held 157,347 shares of Novo Nordisk worth $5.78M as of Q1 2026.
  • Claret Asset Management bought 4,737 Novo Nordisk shares in Q1 2026, an estimated $224K.
  • Novo Nordisk made up 0.69% of Claret Asset Management's portfolio in Q1 2026, its #36 holding.
  • Claret Asset Management first reported a position in Novo Nordisk in Q4 2017 and has held it in 34 quarters since.
  • Claret Asset Management's Novo Nordisk position peaked at $8.05M in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.